These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
845 related articles for article (PubMed ID: 26470960)
1. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method. Bhatia VK; Sharma PC Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey. Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Gupta AK; Kohli Y Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Gupta AK; Kohli Y; Batra R Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561 [TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753 [TBL] [Abstract][Full Text] [Related]
6. In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals. Itoi S; Kano R; Hasegawa A; Kamata H J Vet Med Sci; 2012 Aug; 74(8):1067-9. PubMed ID: 22467073 [TBL] [Abstract][Full Text] [Related]
7. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates. Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes. Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461 [TBL] [Abstract][Full Text] [Related]
11. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains]. Solgun G; Fındık D; Türk Dağı H; Arslan U Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170 [TBL] [Abstract][Full Text] [Related]
12. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis. Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). Barros MEDS; Santos DA; Hamdan JS J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran. Sharifzadeh A; Shokri H; Khosravi AR Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354 [TBL] [Abstract][Full Text] [Related]
16. Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods. Siqueira ER; Ferreira JC; Pedroso RS; Lavrador MA; Candido RC Rev Inst Med Trop Sao Paulo; 2008; 50(1):1-5. PubMed ID: 18327478 [TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium. Sarifakioglu E; Seçkin D; Demirbilek M; Can F Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668 [TBL] [Abstract][Full Text] [Related]
19. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Esteban A; Abarca ML; Cabañes FJ Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608 [TBL] [Abstract][Full Text] [Related]
20. Antidermatophytic activity of allylamine derivatives. Venugopal PV; Venugopal TV Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]